Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. When it involves intra-abdominal lymph nodes, it can lead to significant clinical manifestations, including abdominal pain, lymphadenopathy, and systemic symptoms. Accurate coding with ICD-10 Code C83.13 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C83.13 specifically denotes mantle cell lymphoma affecting intra-abdominal lymph nodes. This code is utilized when documenting cases where MCL presents with lymphadenopathy in the abdominal region, which may complicate the clinical picture. It is crucial for healthcare providers to use this code accurately in clinical documentation and billing to reflect the patient's condition and ensure appropriate treatment and reimbursement.
Mantle cell lymphoma is a hematological malignancy that arises from B-cells and is often aggressive in nature. The intra-abdominal involvement signifies a more advanced stage of the disease, necessitating prompt medical intervention. Symptoms may include abdominal discomfort, weight loss, and night sweats, highlighting the need for timely diagnosis and treatment.
ICD-10 Code C83.13 plays a vital role in SOAP notes by providing a clear diagnosis that guides clinical assessment and treatment planning. It is essential for documenting symptoms, evaluations, and therapeutic interventions in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C83.13 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of mantle cell lymphoma affecting intra-abdominal lymph nodes. This linkage is crucial for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of mantle cell lymphoma with intra-abdominal lymph node involvement often requires urgent medical attention, including hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.13 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential white blood cell count. |
| 77014 | Radiologic guidance for needle placement. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C83.13 for Mantle cell lymphoma, intra-abdominal lymph nodes
What are the common symptoms of mantle cell lymphoma?
Common symptoms include swollen lymph nodes, abdominal pain, unexplained weight loss, fever, and night sweats. Patients may also experience fatigue and other systemic symptoms as the disease progresses.
How is mantle cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies (such as CT scans), and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What treatment options are available for mantle cell lymphoma?
Treatment options may include chemotherapy, targeted therapy, and stem cell transplantation. The choice of treatment depends on the stage of the disease and the patient's overall health.
Is mantle cell lymphoma curable?
While mantle cell lymphoma is considered aggressive and challenging to treat, some patients may achieve remission with appropriate therapy. Ongoing research is focused on improving outcomes and potential cures.
Clinical Notes
SOAP notes
DAP notes
AI medical notes